Aspire Private Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Aspire Private Capital’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50	Closed	-$5K	–	704
2021 Q4	$5K	Hold	50	–	–	﹤0.01%	442
2021 Q3	$3K	Hold	50	–	–	﹤0.01%	472
2021 Q2	$3K	Hold	50	–	–	﹤0.01%	476
2021 Q1	$3K	Hold	50	–	–	﹤0.01%	449
2020 Q4	$4K	Hold	50	–	–	﹤0.01%	337
2020 Q3	$4K	Buy	+50	New	+$3.33K	﹤0.01%	333
2020 Q1	–	Sell	-50	Closed	-$2K	–	521
2019 Q4	$2K	Hold	50	–	–	﹤0.01%	404
2019 Q3	$2K	Hold	50	–	–	﹤0.01%	381
2019 Q2	$3K	Hold	50	–	–	﹤0.01%	376
2019 Q1	$2K	Hold	50	–	–	﹤0.01%	468
2018 Q4	$2K	Buy	+50	New	+$1.96K	﹤0.01%	440

Aspire Private Capital's ARNA Position: Q1 2022 in Review

Aspire Private Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 50 shares — an estimated $5K sold.

Aspire Private Capital first reported a position in ARNA in Q4 2018 and held it in 11 quarters. The position peaked at $5K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Aspire Private Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Aspire Private Capital sold 50 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5K.
Aspire Private Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and held it in 11 quarters.
Aspire Private Capital's Arena Pharmaceuticals Inc position peaked at $5K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Aspire Private Capital's 13F filing for Q1 2022, filed 10 May 2022.